News

Yahoo Finance28d
Iovance Presents Five-Year Amtagvi Data at ASCO for Advanced Melanoma
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) presented five-year data from its Phase 2 C-144-01 trial of Amtagvi (lifileucel) during the 2025 ASCO Annual Meeting. A medical staff in white coats ...
Yahoo Finance28d
Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
SAN CARLOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating ...
Stockhouse25d
IOVA FRAUD: Suffer Losses on Iovance Biotherapeutics, Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NASDAQ:IOVA)
NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and ...
Morningstar23d
Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over Growth Projections Following Stock Plunge – Hagens Berman
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is facing a securities class action lawsuit in the Northern District of California ...
Investing16d
Citizens JMP maintains Iovance stock rating after trial results
On Tuesday, Citizens JMP analysts reiterated a Market Perform rating on Iovance Biotherapeutics stock (NASDAQ: NASDAQ:IOVA), which has declined nearly 80% over the past year. According to ...
The Motley Fool29d
Down More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?
Iovance has a potential blockbuster therapy in its portfolio with Amtagvi, which regulators approved last year. Unfortunately, the rollout has been slower than expected, with the company recently ...
Morningstar29d
IOVA LAWSUIT: Lose Money on Iovance Biotherapeutics, Inc.? Contact BFA Law before July 14 Court Deadline
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ...
Mena FN25d
IOVA FRAUD: Suffer Losses On Iovance Biotherapeutics, Inc.? You May Have Been Affected By Fraud And Are Urged To Contact BFA Law (NASDAQ:IOVA)
(MENAFN- EIN Presswire) NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics ...
Mena FN29d
Shareholders Of Iovance Biotherapeutics, Inc. Should Contact Levi & Korsinsky Before July 14, 2025 To Discuss Your Rights – IOVA
(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or ...
Hosted on MSN23d
Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
Now this is a fine way for a stock to greet the new year. On the back of a glowing analyst recommendation, Iovance Biotherapeutics's (NASDAQ: IOVA) shares closed Thursday more than 5% higher in price.
WAVY-TV16d
IOVA STOCK NOTICE: Iovance Biotherapeutics, Inc. Has Been Sued for Fraud; Investors Are Notified to Contact BFA Law Before July 14 Legal Deadline
NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ ...
FOX8 Cleveland17d
IOVA STOCK ALERT: Iovance Biotherapeutics, Inc. Shareholders With Losses May Have Been Affected by Fraud - Contact BFA Law
NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ ...